Physician profile
John R Schafer
NPI 1386605228
$1,767.83
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,619 · 2020: $87.63 · 2021: $36.25 · 2023: $24.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $269.58 | 2019-2020 | |
| Spineology INC. | $215.18 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.80 | 2019 | |
| Pfizer INC. | $158.38 | 2019-2020 | |
| Radius Health, INC. | $143.82 | 2019 | |
| Vertiflex, INC. | $133.43 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $91.16 | 2019-2020 | |
| Flowonix Medical Incorporated | $71.84 | 2019 | |
| Glaxosmithkline, LLC. | $67.20 | 2019 | |
| Novo Nordisk INC | $65.01 | 2019 | |
| Abbott Laboratories | $51.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.14 | 2019 | |
| Astellas Pharma US INC | $37.93 | 2019 | |
| Collegium Pharmaceutical, INC. | $36.34 | 2019 | |
| Abbvie INC. | $36.25 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.97 | 2019 | |
| Celgene Corporation | $24.77 | 2023 | Zeposia |
| Merck Sharp & Dohme LLC | $18.54 | 2019 | |
| Allergan, INC. | $18.52 | 2020 | |
| Lilly USA, LLC | $16.61 | 2019 | |
| Medtronic Vascular, INC. | $15.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.16 | 2019 | |
| Biodelivery Sciences International, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schafer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.